BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28061869)

  • 21. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
    Karlowsky JA; Biedenbach DJ; Kazmierczak KM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2016 May; 60(5):2849-57. PubMed ID: 26926635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
    Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
    Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal carriage of extended-spectrum beta-lactamase and ampc beta-lactamase-producing enterobacteriaceae in a turkish community.
    Hazirolan G; Mumcuoglu I; Altan G; Özmen BB; Aksu N; Karahan ZC
    Niger J Clin Pract; 2018 Jan; 21(1):81-86. PubMed ID: 29411729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotypic analysis of plasmid-mediated beta-lactamases amongst Enterobacteriaceae other than Escherichia spp. and Klebsiella spp. that are non-susceptible to a broad-spectrum cephalosporin.
    Kiratisin P; Henprasert A
    Int J Antimicrob Agents; 2010 Oct; 36(4):343-7. PubMed ID: 20688485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004).
    Goossens H; Grabein B
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):257-64. PubMed ID: 16360549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
    Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
    Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of extended-spectrum β-lactamase and AmpC β-lactamase-producing Enterobacteriaceae isolated from companion animals in New Zealand.
    Karkaba A; Grinberg A; Benschop J; Pleydell E
    N Z Vet J; 2017 Mar; 65(2):105-112. PubMed ID: 27973988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic characterization of TEM-type ESBL-associated antibacterial resistance in Enterobacteriaceae in a tertiary hospital in Ghana.
    Oduro-Mensah D; Obeng-Nkrumah N; Bonney EY; Oduro-Mensah E; Twum-Danso K; Osei YD; Sackey ST
    Ann Clin Microbiol Antimicrob; 2016 May; 15():29. PubMed ID: 27145868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of ESBL/AmpC genes and specific clones among the third-generation cephalosporin-resistant Enterobacteriaceae from canine and feline clinical specimens in Japan.
    Maeyama Y; Taniguchi Y; Hayashi W; Ohsaki Y; Osaka S; Koide S; Tamai K; Nagano Y; Arakawa Y; Nagano N
    Vet Microbiol; 2018 Mar; 216():183-189. PubMed ID: 29519514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of CLSI and EUCAST Cefepime breakpoint changes on the susceptibility reporting for Enterobacteriaceae.
    Bork JT; Heil EL; Leekha S; Fowler RC; Hanson ND; Majumdar A; Johnson JK
    Diagn Microbiol Infect Dis; 2017 Dec; 89(4):328-333. PubMed ID: 29031525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae.
    Pai H; Kang CI; Byeon JH; Lee KD; Park WB; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3720-8. PubMed ID: 15388426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of the plasmid-mediated quinolone resistance determinant qnrA in multidrug-resistant Enterobacteriaceae from blood cultures in Liverpool, UK.
    Corkill JE; Anson JJ; Hart CA
    J Antimicrob Chemother; 2005 Dec; 56(6):1115-7. PubMed ID: 16260446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical laboratory detection of AmpC β-lactamase: does it affect patient outcome?
    Rand KH; Turner B; Seifert H; Hansen C; Johnson JA; Zimmer A
    Am J Clin Pathol; 2011 Apr; 135(4):572-6. PubMed ID: 21411779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging Perils of Extended Spectrum
    Parajuli NP; Maharjan P; Joshi G; Khanal PR
    Biomed Res Int; 2016; 2016():1782835. PubMed ID: 28119921
    [No Abstract]   [Full Text] [Related]  

  • 35. Large IncHI2-plasmids encode extended-spectrum β-lactamases (ESBLs) in Enterobacter spp. bloodstream isolates, and support ESBL-transfer to Escherichia coli.
    Nilsen E; Haldorsen BC; Sundsfjord A; Simonsen GS; Ingebretsen A; Naseer U; Samuelsen O;
    Clin Microbiol Infect; 2013 Nov; 19(11):E516-8. PubMed ID: 23800169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bloodstream infections caused by qnr-positive Enterobacteriaceae: clinical and microbiologic characteristics and outcomes.
    Chong YP; Choi SH; Kim ES; Song EH; Lee EJ; Park KH; Cho OH; Kim SH; Lee SO; Kim MN; Jeong JY; Woo JH; Kim YS
    Diagn Microbiol Infect Dis; 2010 May; 67(1):70-7. PubMed ID: 20227228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic resistance in Enterobacter cloacae strains with derepressed/partly derepressed/inducible AmpC and extendedspectrum beta-lactamases in Zenica-Doboj Canton, Bosnia and Herzegovina.
    Uzunović S; Ibrahimagić A; Bedenić B
    Med Glas (Zenica); 2018 Feb; 15(1):37-45. PubMed ID: 29214986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type β-lactamases.
    Qureshi ZA; Paterson DL; Peleg AY; Adams-Haduch JM; Shutt KA; Pakstis DL; Sordillo E; Polsky B; Sandkovsky G; Bhussar MK; Doi Y
    Clin Microbiol Infect; 2012 Sep; 18(9):887-93. PubMed ID: 21951551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.